Kirsimari Aaltonen - Concepedia

Author

Kirsimari Aaltonen

Also Known As

Anne Lotz, Dieter Flesch-Janys, Heli Nevanlinna, Hiltrud Brauch, K Aaltonen, Kirsimari Aaltonen, Kristiina Aittomäki, Rebecca Hein, Rita K Schmutzler

Publications

5.5K

Citations

H-Index

Concepts

All Affiliations

Helsinki University Hospital Uppsala University Hospital University of Helsinki Karolinska Institutet Medizinische Hochschule Hannover

About

Kirsimari Aaltonen is an author at Helsinki University Hospital specializing in cancer research, medicine, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.4K
2	Pathology	5	5	1.1K
3	Cell Biology	4	4	515
4	Cancer Epidemiology	2	2	645
5	Cancer Cell Biology	1	1	127

Kirsimari Aaltonen

Publications

Citations

H-Index

Page 1

	Year	Citations
MicroRNA Related Polymorphisms and Breast Cancer Risk Sofia Khan, Dario Greco, Kyriaki Michailidou, PLoS ONE	2014	637
A common coding variant in CASP8 is associated with breast cancer risk Angela Cox, Alison M. Dunning, Montserrat García‐Closas, Nature Genetics Breast OncologyOncologyCancer EpidemiologyBreast Cancer RiskCancer Risk	2007	610
Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics Montserrat García‐Closas, Per Hall, Heli Nevanlinna, PLoS Genetics	2008	395
Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers Juliet D. French, Maya Ghoussaini, Stacey L. Edwards, The American Journal of Human Genetics Breast OncologyOncologyRisk LocusCancer RiskMedicine	2013	214
NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer Rainer Fagerholm, Barbara Hofstetter, Johanna Tommiska, Nature Genetics Breast OncologyPredictive FactorMedicineQuinone Oxidoreductase 1Pathology	2008	208
Aberrations of the MRE11–RAD50–NBS1 DNA damage sensor complex in human breast cancer: <i>MRE11</i> as a candidate familial cancer‐predisposing gene Jiřina Bártková, Johanna Tommiska, Lenka Oplustilova, Molecular Oncology	2008	160
The Breast Cancer Susceptibility Mutation <i>PALB2 1592delT</i> Is Associated with an Aggressive Tumor Phenotype Tuomas Heikkinen, Hanni Kärkkäinen, Kirsimari Aaltonen, Clinical Cancer Research	2009	133
High cyclin B1 expression is associated with poor survival in breast cancer Kirsimari Aaltonen, R-M Amini, Pia Heikkilä, British Journal of Cancer Breast OncologyPoor SurvivalCyclin B1 ExpressionMedicinePathology	2009	127
Prognostic Role of HuR in Hereditary Breast Cancer Mira Heinonen, Rainer Fagerholm, Kirsimari Aaltonen, Clinical Cancer Research Breast OncologyEndocrine-related CancerMedicineEstrogen Receptor NegativityP53 Positivity	2007	105
Mast cells and eosinophils in invasive breast carcinoma Rose‐Marie Amini, Kirsimari Aaltonen, Heli Nevanlinna, BMC Cancer	2007	84

Page 1